BOCA RATON, Fla., August 08, 2022--TherapeuticsMD, Inc. ("TXMD" or the "Company") (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that it will report its second quarter 2022 financial results on Monday, August 15, 2022, at 8:30 a.m. ET prior the opening of the U.S. financial markets.
TherapeuticsMD secured a $15 million equity investment from New York advisory Rubric Capital Management weeks after its deal to be acquired by an affiliate of private equity firm EW Healthcare Partners fell through. The Boca Raton-based women's health care company will use the private investment to fulfill its near-term working capital requirements, according to a news release. “With our investment, TherapeuticsMD will have the time and resources to thoroughly evaluate its strategic options with the objective of securing the best outcome for all shareholders," said David Rosen, managing partner of Rubric Capital.
BOCA RATON, Fla., August 01, 2022--TherapeuticsMD, Inc. (NASDAQ: TXMD), ("TherapeuticsMD" or the "Company") an innovative, leading women’s healthcare company, announced today that it has received a $15 million private investment in the Company’s common stock and a new series of preferred stock ("PIPE") from Rubric Capital Management LP ("Rubric"). TherapeuticsMD expects to use the proceeds from the transaction to fulfill its near-term operating capital requirements.